Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Oct;52(4):479–493. doi: 10.1038/bjc.1985.219

Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumour promotion by phorbol esters and by deep skin wounding.

E K Parkinson
PMCID: PMC1977240  PMID: 2415144

Abstract

Epidermal tumourigenesis can be achieved in rodents by the application of a single subthreshold dose of a carcinogen (initiation) followed by repeated applications of a tumour promoter such as 12-0-tetradecanoyl phorbol, 13-acetate (TPA). TPA induces terminal differentiation in the majority of epidermal keratinocytes in vitro. However, transformed keratinocytes respond weakly to this terminal differentiation signal, and it is suggested that this property allows initiated cells and their progeny to obtain a selective advantage over their normal counterparts during promotion of papilloma formation by TPA. New data are reviewed which suggest that a putative wound hormone TGF-beta has similar differential effects on normal and transformed epithelial cells to those of TPA. It is proposed that the release of TGF-beta from platelets following deep skin wounding may be an explanation as to why wounding is a promoting stimulus but milder forms of epidermal injury are not. Weakly promoting hyperplasiogenic agents are also discussed within the context of a selection theory of tumour promotion.

Full text

PDF
479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Argyris T. S. Epidermal growth following a single application of 12-O-tetradecanoyl-phorbol-13-acetate in mice. Am J Pathol. 1980 Mar;98(3):639–648. [PMC free article] [PubMed] [Google Scholar]
  2. Argyris T. S. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice. Cancer Res. 1983 Apr;43(4):1768–1773. [PubMed] [Google Scholar]
  3. Argyris T. S. Tumor promotion by abrasion induced epidermal hyperplasia in the skin of mice. J Invest Dermatol. 1980 Oct;75(4):360–362. doi: 10.1111/1523-1747.ep12531153. [DOI] [PubMed] [Google Scholar]
  4. Assoian R. K., Komoriya A., Meyers C. A., Miller D. M., Sporn M. B. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983 Jun 10;258(11):7155–7160. [PubMed] [Google Scholar]
  5. BOUTWELL R. K. SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS. Prog Exp Tumor Res. 1964;4:207–250. doi: 10.1159/000385978. [DOI] [PubMed] [Google Scholar]
  6. Balmain A., Pragnell I. B. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature. 1983 May 5;303(5912):72–74. doi: 10.1038/303072a0. [DOI] [PubMed] [Google Scholar]
  7. Balmain A., Ramsden M., Bowden G. T., Smith J. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature. 1984 Feb 16;307(5952):658–660. doi: 10.1038/307658a0. [DOI] [PubMed] [Google Scholar]
  8. Balmain A. Transforming ras oncogenes and multistage carcinogenesis. Br J Cancer. 1985 Jan;51(1):1–7. doi: 10.1038/bjc.1985.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bell G. I. Models of carcinogenesis as an escape from mitotic inhibitors. Science. 1976 May 7;192(4239):569–572. doi: 10.1126/science.130679. [DOI] [PubMed] [Google Scholar]
  10. Belman S., Troll W. The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. Cancer Res. 1972 Mar;32(3):450–454. [PubMed] [Google Scholar]
  11. Bertsch S., Marks F. Lack of an effect of tumor-promoting phorbol esters and of epidermal G1 chalone or DNA synthesis in the epidermis of newborn mice. Cancer Res. 1974 Dec;34(12):3283–3288. [PubMed] [Google Scholar]
  12. Boutwell R. K. The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol. 1974 Jan;2(4):419–443. doi: 10.3109/10408447309025704. [DOI] [PubMed] [Google Scholar]
  13. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982 Jul 10;257(13):7847–7851. [PubMed] [Google Scholar]
  14. Childs C. B., Proper J. A., Tucker R. F., Moses H. L. Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5312–5316. doi: 10.1073/pnas.79.17.5312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Clark-Lewis I., Murray A. W. Tumor promotion and the induction of epidermal ornithine decarboxylase activity in mechanically stimulated mouse skin. Cancer Res. 1978 Mar;38(3):494–497. [PubMed] [Google Scholar]
  16. Colburn N. H., Former B. F., Nelson K. A., Yuspa S. H. Tumour promoter induces anchorage independence irreversibly. Nature. 1979 Oct 18;281(5732):589–591. doi: 10.1038/281589a0. [DOI] [PubMed] [Google Scholar]
  17. Delclos K. B., Nagle D. S., Blumberg P. M. Specific binding of phorbol ester tumor promoters to mouse skin. Cell. 1980 Apr;19(4):1025–1032. doi: 10.1016/0092-8674(80)90093-8. [DOI] [PubMed] [Google Scholar]
  18. DiGiovanni J., Prichett W. P., Decina P. C., Diamond L. DBA/2 mice are as sensitive as SENCAR mice to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis. 1984 Nov;5(11):1493–1498. doi: 10.1093/carcin/5.11.1493. [DOI] [PubMed] [Google Scholar]
  19. Duesberg P. H. Retroviral transforming genes in normal cells? Nature. 1983 Jul 21;304(5923):219–226. doi: 10.1038/304219a0. [DOI] [PubMed] [Google Scholar]
  20. Ebeling J. G., Vandenbark G. R., Kuhn L. J., Ganong B. R., Bell R. M., Niedel J. E. Diacylglycerols mimic phorbol diester induction of leukemic cell differentiation. Proc Natl Acad Sci U S A. 1985 Feb;82(3):815–819. doi: 10.1073/pnas.82.3.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Emerit I., Cerutti P. A. Tumour promoter phorbol-12-myristate-13-acetate induces chromosomal damage via indirect action. Nature. 1981 Sep 10;293(5828):144–146. doi: 10.1038/293144a0. [DOI] [PubMed] [Google Scholar]
  22. Feuerstein N., Cooper H. L. Rapid phosphorylation-dephosphorylation of specific proteins induced by phorbol ester in HL-60 cells. Further characterization of the phosphorylation of 17-kilodalton and 27-kilodalton proteins in myeloid leukemic cells and human monocytes. J Biol Chem. 1984 Mar 10;259(5):2782–2788. [PubMed] [Google Scholar]
  23. Fischer S. M., Mills G. D., Slaga T. J. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis. 1982;3(11):1243–1245. doi: 10.1093/carcin/3.11.1243. [DOI] [PubMed] [Google Scholar]
  24. Fischer S. M., Nelson K. D., Reiners J. J., Jr, Viaje A., Pelling J. C., Slaga T. J. Separation of epidermal cells by density centrifugation: a new technique for studies on normal and pathological differentiation. J Cutan Pathol. 1982 Feb;9(1):43–49. doi: 10.1111/j.1600-0560.1982.tb01040.x. [DOI] [PubMed] [Google Scholar]
  25. Frei J. V., Stephens P. The correlation of promotion of tumour growth and of induction of hyperplasia in epidermal two-stage carcinogenesis. Br J Cancer. 1968 Mar;22(1):83–92. doi: 10.1038/bjc.1968.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Fürstenberger G., Berry D. L., Sorg B., Marks F. Skin tumor promotion by phorbol esters is a two-stage process. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7722–7726. doi: 10.1073/pnas.78.12.7722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Fürstenberger G., Marks F. Early prostaglandin E synthesis is an obligatory event in the induction of cell proliferation in mouse epidermis in vivo by the phorbol ester TPA. Biochem Biophys Res Commun. 1980 Feb 12;92(3):749–756. doi: 10.1016/0006-291x(80)90767-6. [DOI] [PubMed] [Google Scholar]
  28. Fürstenberger G., Schweizer J., Marks F. Development of phorbol ester responsiveness in neonatal mouse epidermis: correlation between hyperplastic response and sensitivity to first-stage tumor promotion. Carcinogenesis. 1985 Feb;6(2):289–294. doi: 10.1093/carcin/6.2.289. [DOI] [PubMed] [Google Scholar]
  29. Fürstenberger G., Sorg B., Marks F. Tumor promotion by phorbol esters in skin: evidence for a memory effect. Science. 1983 Apr 1;220(4592):89–91. doi: 10.1126/science.6828884. [DOI] [PubMed] [Google Scholar]
  30. Gindhart T. D., Srinivas L., Colburn N. H. Benzoyl peroxide promotion of transformation of JB6 mouse epidermal cells: inhibition by ganglioside GT but not retinoic acid. Carcinogenesis. 1985 Feb;6(2):309–311. doi: 10.1093/carcin/6.2.309. [DOI] [PubMed] [Google Scholar]
  31. Goerttler K., Loehrke H., Hesse B., Schweizer J. Skin tumor formation in the European hamster (Cricetus cricetus L.) after topical initiation with 7,12-dimethylbenz[a]anthracene (DMBA) and promotion with 12-O-tetradecanoylphorbol-13-acetate (TPA). Carcinogenesis. 1984 Apr;5(4):521–524. doi: 10.1093/carcin/5.4.521. [DOI] [PubMed] [Google Scholar]
  32. Hennings H., Boutwell R. K. On the mechanism of inhibition of benign and malignant skin tumor formation by actinomycin D. Life Sci. 1967 Jan 15;6(2):173–181. doi: 10.1016/0024-3205(67)90346-3. [DOI] [PubMed] [Google Scholar]
  33. Hennings H., Boutwell R. K. Studies on the mechanism of skin tumor promotion. Cancer Res. 1970 Feb;30(2):312–320. [PubMed] [Google Scholar]
  34. Hennings H., Michael D., Cheng C., Steinert P., Holbrook K., Yuspa S. H. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell. 1980 Jan;19(1):245–254. doi: 10.1016/0092-8674(80)90406-7. [DOI] [PubMed] [Google Scholar]
  35. Hennings H., Shores R., Wenk M. L., Spangler E. F., Tarone R., Yuspa S. H. Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters. Nature. 1983 Jul 7;304(5921):67–69. doi: 10.1038/304067a0. [DOI] [PubMed] [Google Scholar]
  36. Hennings H., Yuspa S. H. Two-stage tumor promotion in mouse skin: an alternative interpretation. J Natl Cancer Inst. 1985 Apr;74(4):735–740. [PubMed] [Google Scholar]
  37. Iannaccone P. M., Gardner R. L., Harris H. The cellular origin of chemically induced tumours. J Cell Sci. 1978 Feb;29:249–269. doi: 10.1242/jcs.29.1.249. [DOI] [PubMed] [Google Scholar]
  38. Johnstone S. R., Stanley M. A., Quigley J. P. The effect of diethylstilboestrol on the in vitro growth of human ectocervical cells. Carcinogenesis. 1984 Jun;5(6):741–745. doi: 10.1093/carcin/5.6.741. [DOI] [PubMed] [Google Scholar]
  39. Kinsella A. R., Radman M. Tumor promoter induces sister chromatid exchanges: relevance to mechanisms of carcinogenesis. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6149–6153. doi: 10.1073/pnas.75.12.6149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kinzel V., Loehrke H., Goerttler K., Fürstenberger G., Marks F. Suppression of the first stage of phorbol 12-tetradecanoate 13-acetate-effected tumor promotion in mouse skin by nontoxic inhibition of DNA synthesis. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5858–5862. doi: 10.1073/pnas.81.18.5858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kinzel V., Richards J., Marks F., Fürstenberger G. Radiomimetic activity of phorbol esters exerted in HeLa cells in comparison with their tumor-promoting capacity. Cancer Res. 1984 Jan;44(1):139–143. [PubMed] [Google Scholar]
  42. Klein-Szanto A. J., Major S. K., Slaga T. J. Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency. Carcinogenesis. 1980 May;1(5):399–406. doi: 10.1093/carcin/1.5.399. [DOI] [PubMed] [Google Scholar]
  43. Klein-Szanto A. J., Major S. K., Slaga T. J. Quantitative evaluation of dark keratinocytes induced by several promoting and hyperplasiogenic agents: their use as an early morphological indicator of tumor-promoting action. Carcinog Compr Surv. 1982;7:305–309. [PubMed] [Google Scholar]
  44. Krieg L., Kühlmann I., Marks F. Effect of tumor-promoting phorbol esters and of acetic acid on mechanisms controlling DNA synthesis and mitosis (Chalones) and on the biosynthesis of histidine-rich protein in mouse epidermis. Cancer Res. 1974 Nov;34(11):3135–3146. [PubMed] [Google Scholar]
  45. Land H., Parada L. F., Weinberg R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature. 1983 Aug 18;304(5927):596–602. doi: 10.1038/304596a0. [DOI] [PubMed] [Google Scholar]
  46. Lawrence N. J., Parkinson E. K., Emmerson A. Benzoyl peroxide interferes with metabolic co-operation between cultured human epidermal keratinocytes. Carcinogenesis. 1984 Mar;5(3):419–421. doi: 10.1093/carcin/5.3.419. [DOI] [PubMed] [Google Scholar]
  47. Lechner J. F., McClendon I. A., LaVeck M. A., Shamsuddin A. M., Harris C. C. Differential control by platelet factors of squamous differentiation in normal and malignant human bronchial epithelial cells. Cancer Res. 1983 Dec;43(12 Pt 1):5915–5921. [PubMed] [Google Scholar]
  48. Lillehaug J. R., Djurhuus R. Effect of diethylstilbestrol on the transformable mouse embryo fibroblast C3H/10T1/2C18 cells. Tumor promotion, cell growth, DNA synthesis, and ornithine decarboxylase. Carcinogenesis. 1982;3(7):797–799. doi: 10.1093/carcin/3.7.797. [DOI] [PubMed] [Google Scholar]
  49. Loehrke H., Schweizer J., Dederer E., Hesse B., Rosenkranz G., Goerttler K. On the persistence of tumor initiation in two-stage carcinogenesis on mouse skin. Carcinogenesis. 1983;4(6):771–775. doi: 10.1093/carcin/4.6.771. [DOI] [PubMed] [Google Scholar]
  50. Marks F., Berry D. L., Bertsch S., Fürstenberger G., Richter H. On the relationship between epidermal hyperproliferation and skin tumor promotion. Carcinog Compr Surv. 1982;7:331–346. [PubMed] [Google Scholar]
  51. Marks F., Bertsch S., Fürstenberger G. Ornithine decarboxylase activity, cell proliferation, and tumor promotion in mouse epidermis in vivo. Cancer Res. 1979 Oct;39(10):4183–4188. [PubMed] [Google Scholar]
  52. Marks F., Bertsch S., Schweizer J. Homeostatic regulation of epidermal cell proliferation. Bull Cancer. 1978;65(2):207–222. [PubMed] [Google Scholar]
  53. Marks F., Fürstenberger G., Kownatzki E. Prostaglandin E-mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A 23187 and by tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1981 Feb;41(2):696–702. [PubMed] [Google Scholar]
  54. Morris R. J., Fischer S. M., Slaga T. J. Evidence that the centrally and peripherally located cells in the murine epidermal proliferative unit are two distinct cell populations. J Invest Dermatol. 1985 Apr;84(4):277–281. doi: 10.1111/1523-1747.ep12265358. [DOI] [PubMed] [Google Scholar]
  55. Morris R., Argyris T. S. Epidermal cell cycle and transit times during hyperplastic growth induced by abrasion or treatment with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1983 Oct;43(10):4935–4942. [PubMed] [Google Scholar]
  56. Mufson R. A., Fischer S. M., Verma A. K., Gleason G. L., Slaga T. J., Boutwell R. K. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5'-monophosphate, and induction of mouse skin tumors in vivo. Cancer Res. 1979 Dec;39(12):4791–4795. [PubMed] [Google Scholar]
  57. Mufson R. A., Steinberg M. L., Defendi V. Effects of 12-O-tetradecanoylphorbol-13-acetate on the differentiation of simian virus 40-infected human keratinocytes. Cancer Res. 1982 Nov;42(11):4600–4605. [PubMed] [Google Scholar]
  58. Murray A. W. Acetic acid pretreatment of initiated epidermis inhibits tumour promotion by a phorbol ester. Experientia. 1978 Nov 15;34(11):1507–1508. doi: 10.1007/BF01932380. [DOI] [PubMed] [Google Scholar]
  59. Nakamura Y., Colburn N. H., Gindhart T. D. Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. Carcinogenesis. 1985 Feb;6(2):229–235. doi: 10.1093/carcin/6.2.229. [DOI] [PubMed] [Google Scholar]
  60. Newbold R. F., Overell R. W. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature. 1983 Aug 18;304(5927):648–651. doi: 10.1038/304648a0. [DOI] [PubMed] [Google Scholar]
  61. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984 Apr 19;308(5961):693–698. doi: 10.1038/308693a0. [DOI] [PubMed] [Google Scholar]
  62. Parkinson E. K., Emmerson A. Non-promoting hyperplasiogenic agents do not mimic the effects of phorbol, 12-myristate, 13-acetate on terminal differentiation of normal and transformed human keratinocytes. Carcinogenesis. 1984 May;5(5):687–690. doi: 10.1093/carcin/5.5.687. [DOI] [PubMed] [Google Scholar]
  63. Parkinson E. K., Emmerson A. The effects of tumour promoters on the multiplication and morphology of cultured human epidermal keratinocytes. Carcinogenesis. 1982;3(5):525–531. doi: 10.1093/carcin/3.5.525. [DOI] [PubMed] [Google Scholar]
  64. Parkinson E. K., Grabham P., Emmerson A. A subpopulation of cultured human keratinocytes which is resistant to the induction of terminal differentiation-related changes by phorbol, 12-myristate, 13-acetate: evidence for an increase in the resistant population following transformation. Carcinogenesis. 1983;4(7):857–861. doi: 10.1093/carcin/4.7.857. [DOI] [PubMed] [Google Scholar]
  65. Parkinson E. K., Pera M. F., Emmerson A., Gorman P. A. Differential effects of complete and second-stage tumour promoters in normal but not transformed human and mouse keratinocytes. Carcinogenesis. 1984 Aug;5(8):1071–1077. doi: 10.1093/carcin/5.8.1071. [DOI] [PubMed] [Google Scholar]
  66. Parry J. M., Parry E. M., Barrett J. C. Tumour promoters induce mitotic aneuploidy in yeast. Nature. 1981 Nov 19;294(5838):263–265. doi: 10.1038/294263a0. [DOI] [PubMed] [Google Scholar]
  67. Pera M. F., Gorman P. A. In vitro analysis of multistage epidermal carcinogenesis: development of indefinite renewal capacity and reduced growth factor requirements in colony forming keratinocytes precedes malignant transformation. Carcinogenesis. 1984 May;5(5):671–682. doi: 10.1093/carcin/5.5.671. [DOI] [PubMed] [Google Scholar]
  68. Raick A. N., Burdzy K. Ultrastructural and biochemical changes induced in mouse epidermis by a hyperplastic agent, ethylphenylpropiolate. Cancer Res. 1973 Oct;33(10):2221–2230. [PubMed] [Google Scholar]
  69. Raick A. N. Cell proliferation and promoting action in skin carcinogenesis. Cancer Res. 1974 May;34(5):920–926. [PubMed] [Google Scholar]
  70. Raick A. N. Late ultrastructural changes induced by 12-O-tetradecanoyl-phorbol-13-acetate in mouse epidermis and their reversal. Cancer Res. 1973 May;33(5):1096–1103. [PubMed] [Google Scholar]
  71. Raick A. N., Thumm K., Chivers B. R. Early effects of 12-O-tetradecanoyl-phorbol-13-acetate on the incorporation of tritiated precursor into DNA and the thickness of the interfollicular epidermis, and their relation to tumor promotion in mouse skin. Cancer Res. 1972 Jul;32(7):1562–1568. [PubMed] [Google Scholar]
  72. Reddy A. L., Fialkow P. J. Papillomas induced by initiation-promotion differ from those induced by carcinogen alone. Nature. 1983 Jul 7;304(5921):69–71. doi: 10.1038/304069a0. [DOI] [PubMed] [Google Scholar]
  73. Reiners J. J., Jr, Nesnow S., Slaga T. J. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis. 1984 Mar;5(3):301–307. doi: 10.1093/carcin/5.3.301. [DOI] [PubMed] [Google Scholar]
  74. Reiners J. J., Jr, Slaga T. J. Effects of tumor promoters on the rate and commitment to terminal differentiation of subpopulations of murine keratinocytes. Cell. 1983 Jan;32(1):247–255. doi: 10.1016/0092-8674(83)90515-9. [DOI] [PubMed] [Google Scholar]
  75. Rheinwald J. G., Beckett M. A. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell. 1980 Nov;22(2 Pt 2):629–632. doi: 10.1016/0092-8674(80)90373-6. [DOI] [PubMed] [Google Scholar]
  76. Ruley H. E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 1983 Aug 18;304(5927):602–606. doi: 10.1038/304602a0. [DOI] [PubMed] [Google Scholar]
  77. Schmidt R., Adolf W., Marston A., Roeser H., Sorg B., Fujiki H., Sugimura T., Moore R. E., Hecker E. Inhibition of specific binding of [3H]phorbol-12,13-dipropionate to an epidermal fraction by certain irritants and irritant promoters of mouse skin. Carcinogenesis. 1983;4(1):77–81. doi: 10.1093/carcin/4.1.77. [DOI] [PubMed] [Google Scholar]
  78. Schwarz J. A., Viaje A., Slaga T. J. Fluocinolone acetonide: a potent inhibitor of mouse skin tumor promotion and epidermal DNA synthesis. Chem Biol Interact. 1977 Jun;17(3):331–347. doi: 10.1016/0009-2797(77)90096-5. [DOI] [PubMed] [Google Scholar]
  79. Schweizer J., Kinjo M., Fürstenberger G., Winter H. Sequential expression of mRNA-encoded keratin sets in neonatal mouse epidermis: basal cells with properties of terminally differentiating cells. Cell. 1984 May;37(1):159–170. doi: 10.1016/0092-8674(84)90311-8. [DOI] [PubMed] [Google Scholar]
  80. Schweizer J., Loehrke H., Hesse B., Goerttler K. 7,12-Dimethylbenz[a]anthracene/12-O-tetradecanoyl-phorbol-13-acetate-mediated skin tumor initiation and promotion in male Sprague-Dawley rats. Carcinogenesis. 1982;3(7):785–789. doi: 10.1093/carcin/3.7.785. [DOI] [PubMed] [Google Scholar]
  81. Scribner J. D., Slaga T. J. Multiple effects of dexamethasone on protein synthesis and hyperplasia caused by a tumor promoter. Cancer Res. 1973 Mar;33(3):542–546. [PubMed] [Google Scholar]
  82. Sisskin E. E., Barrett J. C. Hyperplasia of Syrian hamster epidermis induced by single but not multiple treatments with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1981 Jan;41(1):346–350. [PubMed] [Google Scholar]
  83. Sisskin E. E., Gray T., Barrett J. C. Correlation between sensitivity to tumor promotion and sustained epidermal hyperplasia of mice and rats treated with 12-O-tetra-decanoylphorbol-13-acetate. Carcinogenesis. 1982;3(4):403–407. doi: 10.1093/carcin/3.4.403. [DOI] [PubMed] [Google Scholar]
  84. Slaga T. J., Bowden G. T., Boutwell R. K. Acetic acid, a potent stimulator of mouse epidermal macromolecular synthesis and hyperplasia but with weak tumor-promoting ability. J Natl Cancer Inst. 1975 Oct;55(4):983–987. doi: 10.1093/jnci/55.4.983. [DOI] [PubMed] [Google Scholar]
  85. Slaga T. J., Fischer S. M., Nelson K., Gleason G. L. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3659–3663. doi: 10.1073/pnas.77.6.3659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Slaga T. J., Klein-Szanto A. J., Fischer S. M., Weeks C. E., Nelson K., Major S. Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2251–2254. doi: 10.1073/pnas.77.4.2251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Slaga T. J. Overview of tumor promotion in animals. Environ Health Perspect. 1983 Apr;50:3–14. doi: 10.1289/ehp.83503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Slaga T. J., Scribner J. D. Inhibition of tumor initiation and promotion by anti-inflammatory agents. J Natl Cancer Inst. 1973 Nov;51(5):1723–1725. doi: 10.1093/jnci/51.5.1723. [DOI] [PubMed] [Google Scholar]
  89. Spandidos D. A., Wilkie N. M. Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature. 1984 Aug 9;310(5977):469–475. doi: 10.1038/310469a0. [DOI] [PubMed] [Google Scholar]
  90. Sporn M. B., Roberts A. B., Shull J. H., Smith J. M., Ward J. M., Sodek J. Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science. 1983 Mar 18;219(4590):1329–1331. doi: 10.1126/science.6572416. [DOI] [PubMed] [Google Scholar]
  91. Steinert P., Yuspa S. H. Biochemical evidence for keratinization by mouse epidermal cells in culture. Science. 1978 Jun 30;200(4349):1491–1493. doi: 10.1126/science.566466. [DOI] [PubMed] [Google Scholar]
  92. Sun T. T., Green H. Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope. Cell. 1976 Dec;9(4 Pt 1):511–521. doi: 10.1016/0092-8674(76)90033-7. [DOI] [PubMed] [Google Scholar]
  93. Troll W., Witz G., Goldstein B., Stone D., Sugimura T. The role of free oxygen radicals in tumor promotion and carcinogenesis. Carcinog Compr Surv. 1982;7:593–597. [PubMed] [Google Scholar]
  94. Trosko J. E., Chang C. C., Yotti L. P., Chu E. H. Effect of phorbol myristate acetate on the recovery of spontaneous and ultraviolet light-induced 6-thioguanine and ouabain-resistant Chinese hamster cells. Cancer Res. 1977 Jan;37(1):188–193. [PubMed] [Google Scholar]
  95. Umezawa K., Weinstein I. B., Horowitz A., Fujiki H., Matsushima T., Sugimura T. Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors. Nature. 1981 Apr 2;290(5805):411–413. doi: 10.1038/290411a0. [DOI] [PubMed] [Google Scholar]
  96. Van Duuren B. L., Sivak A., Katz C., Seidman I., Melchionne S. The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res. 1975 Mar;35(3):502–505. [PubMed] [Google Scholar]
  97. Varshavsky A. Phorbol ester dramatically increases incidence of methotrexate-resistant mouse cells: possible mechanisms and relevance to tumor promotion. Cell. 1981 Aug;25(2):561–572. doi: 10.1016/0092-8674(81)90074-x. [DOI] [PubMed] [Google Scholar]
  98. Verma A. K., Ashendel C. L., Boutwell R. K. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1980 Feb;40(2):308–315. [PubMed] [Google Scholar]
  99. Weissman B. E., Aaronson S. A. BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines. Cell. 1983 Feb;32(2):599–606. doi: 10.1016/0092-8674(83)90479-8. [DOI] [PubMed] [Google Scholar]
  100. Willey J. C., Moser C. E., Jr, Lechner J. F., Harris C. C. Differential effects of 12-O-tetradecanoylphorbol-13-acetate on cultured normal and neoplastic human bronchial epithelial cells. Cancer Res. 1984 Nov;44(11):5124–5126. [PubMed] [Google Scholar]
  101. Yuspa S. H., Ben T., Hennings H., Lichti U. Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1982 Jun;42(6):2344–2349. [PubMed] [Google Scholar]
  102. Yuspa S. H., Ben T., Hennings H., Lichti U. Phorbol ester tumor promoters induce epidermal transglutaminase activity. Biochem Biophys Res Commun. 1980 Nov 28;97(2):700–708. doi: 10.1016/0006-291x(80)90321-6. [DOI] [PubMed] [Google Scholar]
  103. Yuspa S. H., Hennings H., Lichti U. Initiator and promoter induced specific changes in epidermal function and biological potential. J Supramol Struct Cell Biochem. 1981;17(3):245–257. doi: 10.1002/jsscb.380170306. [DOI] [PubMed] [Google Scholar]
  104. Yuspa S. H., Kilkenny A. E., Stanley J., Lichti U. Keratinocytes blocked in phorbol ester-responsive early stage of terminal differentiation by sarcoma viruses. Nature. 1985 Apr 4;314(6010):459–462. doi: 10.1038/314459a0. [DOI] [PubMed] [Google Scholar]
  105. Yuspa S. H., Kulesz-Martin M., Ben T., Hennings H. Transformation of epidermal cells in culture. J Invest Dermatol. 1983 Jul;81(1 Suppl):162s–168s. doi: 10.1111/1523-1747.ep12540999. [DOI] [PubMed] [Google Scholar]
  106. Yuspa S. H., Morgan D. L. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature. 1981 Sep 3;293(5827):72–74. doi: 10.1038/293072a0. [DOI] [PubMed] [Google Scholar]
  107. Yuspa S. H., Vass W., Scolnick E. Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals. Cancer Res. 1983 Dec;43(12 Pt 1):6021–6030. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES